Your browser doesn't support javascript.
loading
De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial.
Clark, Richard E; Polydoros, Fotios; Apperley, Jane F; Milojkovic, Dragana; Pocock, Christopher; Smith, Graeme; Byrne, Jenny L; de Lavallade, Hugues; O'Brien, Stephen G; Coffey, Tony; Foroni, Letizia; Copland, Mhairi.
Afiliação
  • Clark RE; Institute of Translational Medicine, University of Liverpool, Liverpool, UK. Electronic address: clarkre@liverpool.ac.uk.
  • Polydoros F; Cancer Research UK Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Apperley JF; Centre for Haematology, Imperial College London at Hammersmith Hospital, London, UK.
  • Milojkovic D; Centre for Haematology, Imperial College London at Hammersmith Hospital, London, UK.
  • Pocock C; East Kent Hospitals, Canterbury, UK.
  • Smith G; Department of Haematology, St James's Hospital, Leeds, UK.
  • Byrne JL; Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
  • de Lavallade H; Department of Haematological Medicine, Kings College Hospital, London, UK.
  • O'Brien SG; Northern Institute for Cancer Research, Newcastle University, Newcastle, UK.
  • Coffey T; Cancer Research UK Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Foroni L; Centre for Haematology, Imperial College London at Hammersmith Hospital, London, UK.
  • Copland M; Paul O'Gorman Leukaemia Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Lancet Haematol ; 4(7): e310-e316, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28566209
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2017 Tipo de documento: Article